Find a Doctor or Practice Location

Medical School: Washington University
Residency: University of Washington Hospital and Clinics

American Academy of Dermatology, National Center for Pharmacoepidemiology Research and Training, Local F1000 Associate Faculty Member, International Medical Dermatology Society, National Society for Investigative Dermatology, National

Hospital Privileges:

• Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
• Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Selected Publications:

Fischer AH, Shin DB, Gelfand JM, Takeshita J: Health Care Utilization for Psoriasis in the United States Differs by Race: An Analysis of the 2001-2013 Medical Expenditures Panel Surveys. Journal of the American Academy of Dermatology 78 (1): 200-203,2018.

Fischer AH, Shin DB, Margolis DJ, Takeshita J: Racial and Ethnic Differences in Health Care Utilization for Childhood Eczema: An Analysis of the 2001-2013 Medical Expenditures Panel Surveys Journal of the American Academy of Dermatology 77 (6): 1060-1067,2017.

Takeshita, J., Gelfand, J.M., Li, P., Pinto, L., Yu, X., Rao, P., Viswanathan, H.N., Doshi, J.A.: Psoriasis in the U.S. Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use. J Invest Dermatol 135 (6): 1057-1065,2015.

Doshi, J.A., Takeshita, J., Pinto, L., Li, P., Yu, X., Rao, P., Viswanathan, H.N., Gelfand, J.M.: Factors Associated with Adherence, Discontinuation, Switching, and Restarting Biologic Therapy Among Psoriasis Patients in the U.S. Medicare Population. Journal of the American Academy of Dermatology 74 (6): 1057-1065,2016.

Takeshita, J., Shin, D.B., Ogdie, A., Gelfand, J.M.: Increased Risk of Pneumonia Among Patients with Psoriasis: A Population-Based Cohort Study in the United Kingdom. J Invest Dermatol 135(Suppl 1) (S50): 2015.

Takeshita, J., Wang, S., Shin, D.B., Mehta, N.N., Kimmel, S.E., Margolis, D.J., Troxel, A.B., Gelfand, J.M.: Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA dermatology 151 (2): 161-9,2015.

Takeshita, J., Callis Duffin, K., Shin, D.B., Krueger, G.G., Robertson, A.D., Troxel, A.B., Van Voorhees, A.S., Gelfand, J.M.: Patient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting. Journal of the American Academy of Dermatology 71 (4): 633-41,2014.

Takeshita, J., Wang, S., Shin, D.B., Callis Duffin, K., Krueger, G.G., Kalb, R.E., Weisman, J.D., Sperber, B.R., Stierstorfer, M.B., Brod, B.A., Schleicher, S.M., Robertson, A.D., Linn, K.A., Shinohara, R.T., Troxel, A.B., Van Voorhees, A.S., Gelfand, J.M.: Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting. Journal of the American Academy of Dermatology 71 (6): 1167-75,2014.

Takeshita, J., Mohler, E.R., Parasuram K., Moore, J., Rogers, W.T., Zhang, L., Gelfand, J.M., Mehta, N.N.: Endothelial cell-, platelet-, and monocyte/macrophage-derived microparticles are elevated in psoriasis beyond cardiometabolic risk factors. Journal of the American Heart Association 3 (1): e000507,2014.

Takeshita, J., Grewal, S., Langan, S.M., Mehta, N.N., Ogdie, A., Van Voorhees, A.S., Gelfand, J.M.: Psoriasis and Comorbid Diseases: Implications for Management. Journal of the American Academy of Dermatology 76 (3): 393,2017.

Takeshita, J., Grewal, S., Langan, S.M., Mehta, N.N., Ogdie, A., Van Voorhees, A.S., Gelfand, J.M.: Psoriasis and Comorbid Diseases: Epidemiology. Journal of the American Academy of Dermatology 76 (3): 377,2017.

Ogdie A, Harter L, Shin D, Baker J, Takeshita J, Choi HK, Love TJ, Gelfand JM.: The Risk of Fracture Among Patients with Psoriatic Arthritis and Psoriasis: A Population-Based Study. Ann Rheum Dis 76 (5): 882,2017.

Jariwala N, Benoit B, Kossenkov AV, Oetjen LK, Whelan TM, Cornejo CM, Takeshita J, Kim BS, Showe LC, Wysocka M, Rook AH.: TIGIT and Helios Are Highly Expressed on CD4+ T Cells in Sézary Syndrome Patients. J Invest Dermatol 137 (1): 257,2017.

Benoit BM, Jariwala N, O'Connor G, Oetjen LK, Whelan TM, Werth A, Troxel AB, Sicard H, Zhu L, Miller C, Takeshita J, McVicar DW, Kim BS, Rook AH, Wysocka M.: CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214. Arch Dermatol Res 309 (1): 11,2017.

Grewal, S.K., Wan, J., Denburg, M.R., Shin, D.B., Takeshita, J., Gelfand, J.M.: The Risk of IgA Nephropathy and Glomerular Disease in Patients with Psoriasis: A Population-Based Cohort Study. Br J Dermatol 176 (5): 1366,2016.

Nelson, C.A., Takeshita, J., Wanat, K.A., Bream, K.D.W., Holms, J.H., Koenig, H.C., Roth, R.R., Vuppalapati, A., James, W.D., Kovarik, C.L.: Impact of Store-and-Forward Teledermatology on Outpatient Dermatologic Care: A Prospective Study in an Urban Underserved Primary Care Setting. Am Acad Dermatol 74 (3): 484-490.e1,2015.

Yeung, H., Takeshita, J., Mehta N.N., Kimmel, S.E., Ogdie, A., Margolis, D.J., Shin, D.B., Attor, R., Troxel, A.B., Gelfand, J.M.: Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatology 149 (10): 1173-9,2013.

Callis Duffin K, Yeung H, Takeshita J, Krueger G G, Robertson A D, Troxel A B, Shin D B, Van Voorhees A S, Gelfand J M: Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. The British Journal of Dermatology 170 (3): 672-80,2014.

Chung, J., Callis Duffin, K., Takeshita, J., Shin, D.B., Krueger, G.G., Robertson, A.D., Troxel, A.B., Van Voorhees, A.S., Edson-Heredia, E., Gelfand, J.M.: Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology 71 (4): 623-32,2014.